These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37092989)

  • 1. Functional Characterization of Plasmid-Borne
    Yang X; Liu X; Chan EW; Zhang R; Chen S
    Microbiol Spectr; 2023 Jun; 11(3):e0308122. PubMed ID: 37092989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae.
    Walker KA; Treat LP; Sepúlveda VE; Miller VL
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963003
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length.
    Ovchinnikova OG; Treat LP; Teelucksingh T; Clarke BR; Miner TA; Whitfield C; Walker KA; Miller VL
    mBio; 2023 Jun; 14(3):e0080023. PubMed ID: 37140436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Klebsiella pneumoniae Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity.
    Walker KA; Miner TA; Palacios M; Trzilova D; Frederick DR; Broberg CA; Sepúlveda VE; Quinn JD; Miller VL
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity.
    Dey T; Chakrabortty A; Kapoor A; Warrier A; Nag VL; Sivashanmugam K; Shankar M
    Microbiol Spectr; 2022 Jun; 10(3):e0039322. PubMed ID: 35647656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany.
    Wahl A; Fischer MA; Klaper K; Müller A; Borgmann S; Friesen J; Hunfeld KP; Ilmberger A; Kolbe-Busch S; Kresken M; Lippmann N; Lübbert C; Marschner M; Neumann B; Pfennigwerth N; Probst-Kepper M; Rödel J; Schulze MH; Zautner AE; Werner G; Pfeifer Y
    Int J Med Microbiol; 2024 Mar; 314():151601. PubMed ID: 38359735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Rodríguez-Medina N; Martínez-Romero E; De la Cruz MA; Ares MA; Valdovinos-Torres H; Silva-Sánchez J; Lozano-Aguirre L; Martínez-Barnetche J; Andrade V; Garza-Ramos U
    Front Microbiol; 2020; 11():579612. PubMed ID: 33391198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microaerobic-mediated suppression of Klebsiella pneumoniae mucoviscosity is restored by rmpD overexpression.
    Sun W; Rong C; Chen L; Li J; An Z; Yue J; Wei H; Han K; Hua M; Zeng H; Chen C
    J Appl Microbiol; 2024 Aug; 135(8):. PubMed ID: 39090973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Tigecycline Nonsusceptible and IMP-4 Carbapenemase-Producing K2-ST65 Hypervirulent Klebsiella pneumoniae in China.
    Zhang Y; Wang X; Wang Q; Chen H; Li H; Wang S; Wang R; Wang H
    Microbiol Spectr; 2021 Oct; 9(2):e0130521. PubMed ID: 34704778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.
    Hsu CR; Lin TL; Chen YC; Chou HC; Wang JT
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3446-3457. PubMed ID: 21964731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.
    Zhou Y; Wu C; Wang B; Xu Y; Zhao H; Guo Y; Wu X; Yu J; Rao L; Wang X; Yu F
    Drug Resist Updat; 2023 Mar; 67():100918. PubMed ID: 36610180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface.
    Cubero M; Marti S; Domínguez MÁ; González-Díaz A; Berbel D; Ardanuy C
    PLoS One; 2019; 14(9):e0222628. PubMed ID: 31532800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness.
    Mike LA; Stark AJ; Forsyth VS; Vornhagen J; Smith SN; Bachman MA; Mobley HLT
    PLoS Pathog; 2021 Mar; 17(3):e1009376. PubMed ID: 33720976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and 'non-hypervirulent' types ST147, ST15 and ST383.
    Turton JF; Payne Z; Coward A; Hopkins KL; Turton JA; Doumith M; Woodford N
    J Med Microbiol; 2018 Jan; 67(1):118-128. PubMed ID: 29205138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.
    Struve C; Roe CC; Stegger M; Stahlhut SG; Hansen DS; Engelthaler DM; Andersen PS; Driebe EM; Keim P; Krogfelt KA
    mBio; 2015 Jul; 6(4):e00630. PubMed ID: 26199326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Two Regulators of Virulence That Are Conserved in
    Palacios M; Miner TA; Frederick DR; Sepulveda VE; Quinn JD; Walker KA; Miller VL
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087173
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
    Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
    mSphere; 2021 May; 6(3):. PubMed ID: 34011682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Extensively Drug-Resistant and Hypervirulent KL2-ST65 Klebsiella pneumoniae Harboring
    Liu C; Du P; Yang P; Yi J; Lu M; Shen N
    Microbiol Spectr; 2022 Dec; 10(6):e0304422. PubMed ID: 36374105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genetic analysis of the antimicrobial susceptibilities and virulence of hypermucoviscous and non-hypermucoviscous ESBL-producing Klebsiella pneumoniae in Japan.
    Tanimoto H; Shigemura K; Osawa K; Kado M; Onishi R; Fang SB; Sung SY; Miyara T; Fujisawa M
    J Microbiol Immunol Infect; 2023 Feb; 56(1):93-103. PubMed ID: 36068121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypermucoviscosity of hypervirulent
    Xu Q; Yang X; Chan EWC; Chen S
    Virulence; 2021 Dec; 12(1):2050-2059. PubMed ID: 34339346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.